ARTICLE | Company News
Perlegen sales and marketing update
September 28, 2009 7:00 AM UTC
Perlegen launched its BREVAGen breast cancer stratification test in selected U.S. markets. The test combines a DNA-based profile of breast cancer-associated SNPs with the patient's clinical history t...